Pleun Beelen1,2, Marian J van den Brink3, Malou C Herman4, Peggy M Geomini5, Ruben G Duijnhoven6, Marlies Y Bongers5,7. 1. Department of Obstetrics and Gynecology, Máxima MC, 5504 DB, Veldhoven, The Netherlands. pleun.beelen@gmail.com. 2. Department of General Practice, University of Maastricht, Maastricht, The Netherlands. pleun.beelen@gmail.com. 3. Department of General Practice and Elderly Care Medicine, University of Groningen, University Medical Centre Groningen, Groningen, The Netherlands. 4. Department of Obstetrics and Gynecology, Jeroen Bosch Hospital, 's Hertogenbosch, The Netherlands. 5. Department of Obstetrics and Gynecology, Máxima MC, 5504 DB, Veldhoven, The Netherlands. 6. Department of Obstetrics and Gynecology, Academic Medical Centre, Amsterdam, The Netherlands. 7. Research School Grow, University of Maastricht, Maastricht, The Netherlands.
Abstract
BACKGROUND: This study was conducted to identify factors that are associated with failure of treatment using the levonorgestrel releasing intrauterine system (LNG-IUS) in women with heavy menstrual bleeding. METHODS: For this study, data of a cohort of women treated with an LNG-IUS was used. Women who suffered from heavy menstrual bleeding, aged 34 years and older, without intracavitary pathology and without a future child wish, were recruited in hospitals and general practices in the Netherlands. Eight potential prognostic baseline variables (age, body mass index, caesarean section, vaginal delivery, previous treatment, anticoagulant use, dysmenorrhea, and pictorial blood assessment score) were analyzed using univariable and multivariable regression models to estimate the risk of failure. The main outcome measure was discontinuation of the LNG-IUS within 24 months of follow up, defined as removal of the LNG-IUS or receiving an additional intervention. RESULTS: A total of 209 women received the LNG-IUS, 201 women were included in the analyses. 93 women (46%) discontinued LNG-IUS treatment within 24 months. Multivariable analysis showed younger age (age below 45) (adjusted RR 1.51, 95% CI 1.10-2.09, p = .012) and severe dysmenorrhea (adjusted RR 1.36, 95% CI 1.01-1.82, p = .041) to be associated with a higher risk of discontinuation. CONCLUSIONS: High discontinuation rates are found in women who receive an LNG-IUS to treat heavy menstrual bleeding. A younger age and severe dysmenorrhea are found to be risk factors for discontinuation of LNG-IUS treatment. These results are relevant for counselling women with heavy menstrual bleeding.
BACKGROUND: This study was conducted to identify factors that are associated with failure of treatment using the levonorgestrel releasing intrauterine system (LNG-IUS) in women with heavy menstrual bleeding. METHODS: For this study, data of a cohort of women treated with an LNG-IUS was used. Women who suffered from heavy menstrual bleeding, aged 34 years and older, without intracavitary pathology and without a future child wish, were recruited in hospitals and general practices in the Netherlands. Eight potential prognostic baseline variables (age, body mass index, caesarean section, vaginal delivery, previous treatment, anticoagulant use, dysmenorrhea, and pictorial blood assessment score) were analyzed using univariable and multivariable regression models to estimate the risk of failure. The main outcome measure was discontinuation of the LNG-IUS within 24 months of follow up, defined as removal of the LNG-IUS or receiving an additional intervention. RESULTS: A total of 209 women received the LNG-IUS, 201 women were included in the analyses. 93 women (46%) discontinued LNG-IUS treatment within 24 months. Multivariable analysis showed younger age (age below 45) (adjusted RR 1.51, 95% CI 1.10-2.09, p = .012) and severe dysmenorrhea (adjusted RR 1.36, 95% CI 1.01-1.82, p = .041) to be associated with a higher risk of discontinuation. CONCLUSIONS: High discontinuation rates are found in women who receive an LNG-IUS to treat heavy menstrual bleeding. A younger age and severe dysmenorrhea are found to be risk factors for discontinuation of LNG-IUS treatment. These results are relevant for counselling women with heavy menstrual bleeding.
Entities:
Keywords:
Failure; Heavy menstrual bleeding; Levonorgestrel intrauterine system; Prognosis
Authors: Marko Elovainio; Juha Teperi; Anna-Mari Aalto; Seija Grenman; Aarre Kivelä; Erkki Kujansuu; Sirkku Vuorma; Merja Yliskoski; Jorma Paavonen; Ritva Hurskainen Journal: Int J Behav Med Date: 2007
Authors: Pleun Beelen; Marian J van den Brink; Malou C Herman; Peggy M A J Geomini; Janny H Dekker; Ruben G Duijnhoven; Nienke Mak; Hannah S van Meurs; Sjors F Coppus; Jan Willem van der Steeg; Heleen P Eising; Diana S Massop-Helmink; Ellen R Klinkert; Theodoor E Nieboer; Anne Timmermans; Lucet F van der Voet; Sebastiaan Veersema; Nicol A C Smeets; Joke M Schutte; Marchien van Baal; Patrick M Bossuyt; Ben Willem J Mol; Marjolein Y Berger; Marlies Y Bongers Journal: Am J Obstet Gynecol Date: 2020-08-12 Impact factor: 8.661
Authors: Malou C Herman; Marian J van den Brink; Peggy M Geomini; Hannah S van Meurs; Judith A Huirne; Heleen P Eising; Anne Timmermans; Johanna M A Pijnenborg; Ellen R Klinkert; Sjors F Coppus; Theodoor E Nieboer; Ruby Catshoek; Lucet F van der Voet; Hugo W F van Eijndhoven; Giuseppe C M Graziosi; Sebastiaan Veersema; Paul J van Kesteren; Josje Langenveld; Nicol A C Smeets; Huib A A M van Vliet; Jan Willem van der Steeg; Yvonne Lisman-van Leeuwen; Janny H Dekker; Ben W Mol; Marjolein Y Berger; Marlies Y Bongers Journal: BMC Womens Health Date: 2013-08-08 Impact factor: 2.809
Authors: Maarten van Smeden; Karel Gm Moons; Joris Ah de Groot; Gary S Collins; Douglas G Altman; Marinus Jc Eijkemans; Johannes B Reitsma Journal: Stat Methods Med Res Date: 2018-07-03 Impact factor: 3.021